A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...

A well-known injectable birth control method is under fire after multiple studies linked it to a specific kind of brain tumor, and now, lawsuits are piling up against the drugmaker. […] The post ...

The hormonal treatments cyproterone acetate and medroxyprogesterone acetate are the most effective at reducing hot flushes, a common side-effect in men being treated with hormone therapy for ...

A new study allegedly discovered that women using a specific form of birth control had a "significantly higher risk" of ...

Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...

On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...

Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune ...

The medroxyprogesterone acetate first came into use in 1958 and is on the list of World Health Organisation's list prestigious list of Essential Medicines, a list of safe and effective medicines.

Men with prostate cancer who reported having significant hot flushes during androgen suppression treatment had a better hormonal response with cyproterone and medroxyprogesterone compared with ...

What Is Medroxyprogesterone Acetate? MPA is normally used to regulate ovulation and menstruation, as well as to help prevent complications associated with estrogen therapy in postmenopausal women.

Use of the injectable contraceptive depot medroxyprogesterone acetate, common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune response ...